Integra LifeSciences Holdings Corporation’s (NASDAQ:IART) 28% Dip In Price Shows Sentiment Is Matching Revenues
Unfortunately for some shareholders, the Integra LifeSciences Holdings Corporation (NASDAQ:IART) share price has dived 28% in the last thirty days, prolonging recent pain. The recent drop completes a disastrous twelve months for shareholders, who are sitting on a 53% loss during that time.
Following the heavy fall in price, Integra LifeSciences Holdings may look like a strong buying opportunity at present with its price-to-sales (or “P/S”) ratio of 0.6x, considering almost half of all companies in the Medical Equipment industry in the United States have P/S ratios greater than 2.8x and even P/S higher than 7x aren’t out of the ordinary. Although, it’s not wise to just take the P/S at face value as there may be an explanation…
